Blood Transfusion, Auxiliary Products


Combined with:

Exjade

Indications and Reactions:

Role Indications Reactions
Secondary
Prophylaxis Against Graft Versus Host Disease 52.9%
Pancreatic Neuroendocrine Tumour 5.9%
Diabetes Mellitus 4.4%
Drug Use For Unknown Indication 2.9%
Gastrooesophageal Reflux Disease 2.9%
Haemoglobin Decreased 2.9%
Myelofibrosis 2.9%
Paroxysmal Nocturnal Haemoglobinuria 2.9%
Refractory Anaemia 2.9%
Renal Failure Chronic 2.9%
Thalassaemia 2.9%
Atrial Fibrillation 1.5%
Gastrointestinal Stromal Tumour 1.5%
Haemorrhage 1.5%
Hypertension 1.5%
Iron Overload 1.5%
Migraine 1.5%
Myelodysplastic Syndrome 1.5%
Splenomegaly 1.5%
Type 2 Diabetes Mellitus 1.5%
Haemoglobin Decreased 11.1%
Rash Maculo-papular 11.1%
Aortic Valve Incompetence 5.6%
Cardiac Failure 5.6%
Dysstasia 5.6%
Gastric Ulcer Haemorrhage 5.6%
Hepatitis C 5.6%
Pulmonary Hypertension 5.6%
Pyrexia 5.6%
Rash 5.6%
Renal Impairment 5.6%
Serum Ferritin Increased 5.6%
Skin Lesion 5.6%
Transplant Failure 5.6%
Transplant Rejection 5.6%
Underdose 5.6%
Concomitant
Product Used For Unknown Indication 15.1%
Iron Overload 14.3%
Prophylaxis 10.7%
Myelodysplastic Syndrome 8.4%
Hypertension 6.5%
Aplastic Anaemia 6.0%
Multiple Myeloma 5.3%
Anaemia 5.3%
Acute Myeloid Leukaemia 3.3%
Osteoporosis 3.3%
Paroxysmal Nocturnal Haemoglobinuria 2.9%
Cancer Pain 2.8%
Pain 2.5%
Chronic Myeloid Leukaemia 2.2%
Sickle Cell Anaemia 2.1%
Prostate Cancer Metastatic 2.0%
Infection 2.0%
Diabetes Mellitus 1.8%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Aplasia Pure Red Cell 1.6%
Vomiting 11.4%
Pancytopenia 8.6%
Weight Decreased 7.3%
Pyrexia 6.9%
Serum Ferritin Increased 6.5%
Urinary Tract Infection 5.3%
Weight Increased 5.3%
White Blood Cell Count Decreased 5.3%
Viral Infection 4.9%
Death 4.5%
Sepsis 4.5%
Thrombocytopenia 4.5%
Fatigue 4.1%
Diarrhoea 3.3%
Pneumonia 3.3%
White Blood Cell Count Increased 3.3%
Renal Failure 2.9%
Terminal State 2.9%
Wheezing 2.9%
Anxiety 2.4%

Drug Data